Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Heteroaryl acid morpholinone compounds as MDM2 inhibitors for the treatment of cancer

Heteroaryl acid morpholinone compounds as MDM2 inhibitors for the treatment of cancer

US Patent 9758495 · Granted Sep 12, 2017

Estimated economic value: $336,979,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Fluoroalkyl-oxadiazoles and uses thereof2025
Fluoroalkyl-oxadiazoles and uses thereof2025
EP2 antagonist compounds2025
Bridged tricyclic carbamoylpyridone compounds and their pharmaceutical use2025
Substituted pyridotriazine compounds and uses thereof2025
Opioid receptor modulators2024
Opioid receptor modulators2024
Bridged tricyclic carbamoylpyridone compounds and uses thereof2024
Bridged tricyclic carbamoylpyridone compounds and uses thereof2024
Fluoroalkyl-oxadiazoles and uses thereof2024
Substituted pyridotriazine compounds and uses thereof2024
Opioid receptor modulators2023